Market Tracker

10/23 6:05pm ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.90
Data as of Oct 23
 +0.02 / +1.07%
Today’s Change
1.53
Today|||52-Week Range
3.79
-38.27%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close1.88
Today’s open1.89
Day’s range1.86 - 1.96
Volume72,850
Average volume (3 months)187,164
Market cap$42.6M
Dividend yield--
Data as of 3:57pm ET, 10/23/2014

Growth & Valuation

Earnings growth (last year)+79.49%
Earnings growth (this year)+14.23%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.47

Competitors

 Today’s
change
Today’s
% change
ENZNEnzon Pharmaceutical...+0.05+4.62%
CPXXCelator Pharmaceutic...+0.53+30.81%
BLRXBioLine RX Ltd+0.03+2.26%
HTBXHeat Biologics Inc+0.13+2.15%
Data as of 3:59pm ET, 10/23/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$0.00
Annual profit (last year)-$30.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul F. Truex
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts